REMESCAR

Vemedia is a fast-growing consumer health company, marketing self-medication brands. Philips Duphar and Gist Brocades created Vemedia in 1961 initially as a veterinary medicine business and soon after personal care drugs and pesticides were added to the portfolio.

In 2002, Yvan Vindevogel acquired Vemedia from Solvay and over the next decade following an "acquire and build strategy", the group acquired a number of businesses that substantially increased sales of its brand portfolio and expanded its geographic presence in Europe and several emerging markets. Major milestones included the acquisition of Viatris in 2006 and Valdispert in 2008.

To pursue its ambitious growth strategy, Vemedia sought a financial partner and, in 2012, IK Investment Partners took a substantial stake in the Company, and Yvan Vindevogel and management became minority shareholders.

At the end of 2012, Vemedia acquired Excilor, a leading OTC brand in the treatment of fungal nail infections. In 2013, under new ownership, Vemedia entered the French market and during that year sold its chemical compounding business, enabling Vemedia to become a virtually exclusive OTC company with a broad product portfolio.